Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Porter

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Clinical Obstetrics and Gynecology|February 24, 2001
Antiphospholipid antibodies and infertilityT F Porter
Clinical Obstetrics and Gynecology|November 26, 1999
Deep venous thrombosis: prophylaxis in gynecologyS Madden, T F Porter
Seminars in Reproductive Medicine|May 18, 2001
Alloimmune causes of recurrent pregnancy lossT F Porter, J R Scott
Clinical Obstetrics and Gynecology|November 5, 1997
Using evidence-based medicine to optimize cesarean section outcomesT F Porter, M W Varner
Obstetrics and Gynecology Clinics of North America|December 10, 1999
Vibroacoustic and scalp stimulationT F Porter, S L Clark
The Cochrane Database of Systematic Reviews|April 21, 2006
Immunotherapy for recurrent miscarriageT F Porter, Y LaCoursiere, J R Scott
Obstetrics and Gynecology|June 1, 2000
Coumarin derivatives and breast-feedingS L Clark, T F Porter, F G West
Lupus|April 1, 2010
Obstetric antiphospholipid syndrome: current uncertainties should guide our wayD W Branch, R M Silver, T F Porter
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 1, 1997
Potential of immunotherapeutic treatment for recurrent pregnancy lossD J Dudley, T F Porter, J R Scott
American Journal of Obstetrics and Gynecology|October 28, 1998
Institutional influences on the primary cesarean section rate in Utah, 1992 to 1995S L Clark, W Xu, T F Porter, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Clinical Obstetrics and Gynecology|February 24, 2001
Antiphospholipid antibodies and infertilityT F Porter
Clinical Obstetrics and Gynecology|November 26, 1999
Deep venous thrombosis: prophylaxis in gynecologyS Madden, T F Porter
Seminars in Reproductive Medicine|May 18, 2001
Alloimmune causes of recurrent pregnancy lossT F Porter, J R Scott
Clinical Obstetrics and Gynecology|November 5, 1997
Using evidence-based medicine to optimize cesarean section outcomesT F Porter, M W Varner
Obstetrics and Gynecology Clinics of North America|December 10, 1999
Vibroacoustic and scalp stimulationT F Porter, S L Clark
The Cochrane Database of Systematic Reviews|April 21, 2006
Immunotherapy for recurrent miscarriageT F Porter, Y LaCoursiere, J R Scott
Obstetrics and Gynecology|June 1, 2000
Coumarin derivatives and breast-feedingS L Clark, T F Porter, F G West
Lupus|April 1, 2010
Obstetric antiphospholipid syndrome: current uncertainties should guide our wayD W Branch, R M Silver, T F Porter
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 1, 1997
Potential of immunotherapeutic treatment for recurrent pregnancy lossD J Dudley, T F Porter, J R Scott
American Journal of Obstetrics and Gynecology|October 28, 1998
Institutional influences on the primary cesarean section rate in Utah, 1992 to 1995S L Clark, W Xu, T F Porter, et al.
Pageof 3